BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 23121974)

  • 21. Isolation of mesenchymal stromal cells from extraembryonic tissues and their characteristics.
    Veryasov VN; Savilova AM; Buyanovskaya OA; Chulkina MM; Pavlovich SV; Sukhikh GT
    Bull Exp Biol Med; 2014 May; 157(1):119-24. PubMed ID: 24909727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.
    Seo MS; Park SB; Kang KS
    Cell Transplant; 2012; 21(7):1493-502. PubMed ID: 22732242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.
    Zhou C; Yang B; Tian Y; Jiao H; Zheng W; Wang J; Guan F
    Cell Immunol; 2011; 272(1):33-8. PubMed ID: 22004796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.
    Deuse T; Stubbendorff M; Tang-Quan K; Phillips N; Kay MA; Eiermann T; Phan TT; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S
    Cell Transplant; 2011; 20(5):655-67. PubMed ID: 21054940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human umbilical cord Wharton's jelly mesenchymal stem cells combined with an acellular cartilage extracellular matrix scaffold improve cartilage repair compared with microfracture in a caprine model.
    Zhang Y; Liu S; Guo W; Wang M; Hao C; Gao S; Zhang X; Li X; Chen M; Jing X; Wang Z; Peng J; Lu S; Guo Q
    Osteoarthritis Cartilage; 2018 Jul; 26(7):954-965. PubMed ID: 29391278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.
    Fong CY; Subramanian A; Biswas A; Bongso A
    J Cell Biochem; 2016 Apr; 117(4):815-27. PubMed ID: 26365815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restricted myogenic potential of mesenchymal stromal cells isolated from umbilical cord.
    Grabowska I; Brzoska E; Gawrysiak A; Streminska W; Moraczewski J; Polanski Z; Hoser G; Kawiak J; Machaj EK; Pojda Z; Ciemerych MA
    Cell Transplant; 2012; 21(8):1711-26. PubMed ID: 22525423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the ultrastructural and immunophenotypic characteristics of human umbilical cord-derived mesenchymal stromal cells and in situ cells in Wharton's jelly.
    Ryu YJ; Seol HS; Cho TJ; Kwon TJ; Jang SJ; Cho J
    Ultrastruct Pathol; 2013 May; 37(3):196-203. PubMed ID: 23650992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
    Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S
    Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells in type I collagen-hydrogel for cartilage engineering.
    Chen X; Zhang F; He X; Xu Y; Yang Z; Chen L; Zhou S; Yang Y; Zhou Z; Sheng W; Zeng Y
    Injury; 2013 Apr; 44(4):540-9. PubMed ID: 23337703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathways reflecting poor intrauterine growth are found in Wharton's jelly-derived mesenchymal stem cells.
    Sukarieh R; Joseph R; Leow SC; Li Y; Löffler M; Aris IM; Tan JH; Teh AL; Chen L; Holbrook JD; Ng KL; Lee YS; Chong YS; Summers SA; Gluckman PD; Stünkel W
    Hum Reprod; 2014 Oct; 29(10):2287-301. PubMed ID: 25129543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.
    Weiss ML; Medicetty S; Bledsoe AR; Rachakatla RS; Choi M; Merchav S; Luo Y; Rao MS; Velagaleti G; Troyer D
    Stem Cells; 2006 Mar; 24(3):781-92. PubMed ID: 16223852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wharton's Jelly stem cells: future clinical applications.
    Taghizadeh RR; Cetrulo KJ; Cetrulo CL
    Placenta; 2011 Oct; 32 Suppl 4():S311-5. PubMed ID: 21733573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene screening of Wharton's jelly derived stem cells.
    Mechiche Alami S; Velard F; Draux F; Siu Paredes F; Josse J; Lemaire F; Gangloff SC; Graesslin O; Laurent-Maquin D; Kerdjoudj H
    Biomed Mater Eng; 2014; 24(1 Suppl):53-61. PubMed ID: 24928918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
    Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells.
    Roy S; Arora S; Kumari P; Ta M
    Cryobiology; 2014 Jun; 68(3):467-72. PubMed ID: 24704519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells.
    Subramanian A; Shu-Uin G; Kae-Siang N; Gauthaman K; Biswas A; Choolani M; Bongso A; Chui-Yee F
    J Cell Biochem; 2012 Jun; 113(6):1886-95. PubMed ID: 22234854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.